| Affiliation: | 1. Haematology Unit, A.O., Cosenza, Italy;2. Biotecnology Research Unit, Aprigliano (CS), ItalyContributed equally to the study.;3. Department of Clinical and Community Science, University of Milan, Milan, Italy;4. Haematology Unit, Foundation IRCCS Cà Granda‐Policlinico Hospital, Milan, Italy;5. SS di Diagnostica Molecolare IRCCS S. Martino‐IST, Genova, Italy;6. Laboratory of Pre‐Clinical and Translational Research, IRCCS‐CROB, Referral Cancer Centre of Basilicata, Rionero in Vulture (PZ), Italy;7. Scientific Division, IRCCS S. Martino‐National Cancer Institute, Genova, Italy;8. Biotecnology Research Unit, Aprigliano (CS), Italy;9. Haematology Unit, Maria Nuova Civil Hospital of Reggio Emilia, Reggio Emilia, Italy;10. Haematology‐Oncology Unit, Garibaldi‐Nesima Hospital, Catania, Italy;11. Haematology Unit, A.O., Reggio Calabria, Italy;12. GISL Trial Office, Modena, Italy;13. Haematology Unit, University of Messina, Messina, Italy;14. Haematology Unit AO, Catanzaro, Italy;15. Department of Clinical and Molecular Biomedicine, Section of Haematology, Ferrarotto Hospital, University of Catania, Catania, Italy |
